An Act to ensure prescription drug cost transparency and affordability

This bill amends Massachusetts laws to improve transparency and affordability for prescription drugs by updating how different types of medications are defined. It specifically clarifies the legal definitions of biosimilars, brand name drugs, and generic drugs to ensure consistency across the state's healthcare system. Additionally, the legislation expands coverage to include self-insured health plans, which were previously excluded from certain reporting requirements. By refining these categories and broadening the scope of included plans, the bill aims to provide clearer data on drug costs for consumers and insurers.